Ten checks before a GenAI project gets funded

Author: Praveen Nirapure, Innovation & Solutions | Gaurav Gupta, Account Delivery Head

Introduction

Generative AI has become one of the most disruptive forces in enterprise technology. It sits at the intersection of data, automation, and customer experience, and is now shaping boardroom agendas across industries. Every strategic plan, every digital transformation roadmap, and every innovation pipeline has a reference to GenAI. Yet many enterprises are still asking a fundamental question: should this technology be applied to our specific problem?
The answer is rarely straightforward. GenAI projects are complex. They touch infrastructure, governance, risk management, data strategy, and operating models. A wrong decision can waste millions in sunk costs, disrupt ongoing workflows, and create regulatory liabilities. A right decision, however, can accelerate operational efficiency, create new sources of revenue, and establish competitive advantage.
This article is designed as a decision guide. Not to push you into or away from GenAI, but to help frame the factors that determine whether a given enterprise problem is suitable for GenAI adoption. The aim is to help senior executives think in a structured way, so that the technology can be applied with discipline, confidence, and measurable outcomes.

Organizational Readiness

Many enterprises underestimate the importance of readiness. GenAI cannot be bolted onto existing systems without careful preparation. Before any initiative begins, enterprises should evaluate their cloud maturity, data pipeline capabilities, and account management infrastructure.
Ask whether the enterprise has existing data pipelines for preprocessing and cleansing. Assess whether the IT organization can handle GPU-based infrastructure and advanced orchestration. Determine whether you have sufficient MLOps and AIOps expertise to manage model lifecycle, versioning, and monitoring. These capabilities form the foundation. Without them, GenAI pilots may succeed, but scaling into production will fail.
Readiness includes governance models, budget allocation, and clear executive sponsorship. Without these, GenAI projects risk remaining experimental rather than transformative.
While might seem overwhelming, and arguably is indeed a big undertaking, this guide is intended to give you clear action plans that can ease the decision-making process.

The Guide to GenAI

Software and Hardware Architecture

The choice of architecture determines scalability, performance, and cost. Enterprises must define whether they require large-scale general-purpose models or smaller domain-specific models fine-tuned for vertical tasks. The architecture also dictates hardware requirements—high-end GPUs, distributed CPU clusters, or hybrid setups. While using in-house compute favours scalability and security, it is capital intensive. The alternatives include Cloud computing services for an easier start, especially for pay-as-you-go business models.
Integration into the enterprise SDLC is critical. GenAI cannot exist in a silo. It must integrate into CI/CD pipelines, version control systems, and enterprise observability stacks. Model retraining, deployment automation, and rollback processes should be designed upfront, not after issues appear in production.
A strong architectural review should answer: what is the expected scale of data and users, how will the model be retrained, what preprocessing pipelines are needed, and what dependencies must be orchestrated across existing IT systems. Having the dataflow penned at the beginning will boost scalability while also setting clear KPIs for the engineering teams.

Data Sensitivity and Storage Strategy

Data is the lifeblood of GenAI systems. Enterprises must conduct a rigorous sensitivity assessment before committing datasets to training or inference. The classification should cover personally identifiable information (PII), regulated data (such as health or financial records), and proprietary intellectual property.
Based on this classification, storage and access policies must be designed. Will the data live in public cloud, private cloud, or on-premises? What retention and backup requirements apply? How will lineage and metadata be maintained?
Enterprises should also assess data quality and coverage. Ensuring minimum internal quality standards for the data, complete documentation and cataloguing, and also asking how will trust be built with internal and external stakeholders regarding the use of data for AI purposes?
Without a coherent storage and data strategy, GenAI initiatives risk either compliance violations or poor model performance due to inconsistent training sets.

Risk, Compliance, and Governance

No GenAI initiative should proceed without a comprehensive risk and compliance assessment. Regulatory obligations vary by industry and geography—GDPR, HIPAA, CCPA, or financial sector-specific mandates all introduce constraints.
In addition to external regulations, enterprises must define internal AI governance frameworks. This includes strong data access controls, responsible AI guidelines, bias detection protocols, and ethical use policies. Many leading organizations now implement AI ethics boards to review projects and ensure alignment with corporate values.
Executives must also evaluate liability. If a GenAI system operates in a safety-critical environment like healthcare or makes decisions with significant financial consequences, liability risk increases. For these contexts, deterministic systems should remain the default, with GenAI used only in advisory roles.

Integration into Enterprise Systems

Even if a GenAI model produces useful output, its enterprise value depends on integration. Executives should require clear integration blueprints that define how data flows into and out of the system.
Key questions include: Which APIs will connect the GenAI service to upstream and downstream applications? What event-driven architectures or message queues will orchestrate workflows? How will outputs be validated before being ingested into ERP or CRM systems?
Shadow AI—unmanaged applications built outside IT governance—must be avoided. Integration should occur through enterprise-approved frameworks, ensuring security, observability, and maintainability.

Testing and Evaluation Readiness

Testing in GenAI is more complex than in traditional software. Deterministic systems allow for binary pass-fail outcomes. Probabilistic systems require multidimensional evaluation.
Executives should mandate evaluation protocols before projects begin. This includes holdout datasets, human-in-the-loop evaluations, and red-teaming exercises designed to expose weaknesses. Key metrics may include precision, recall, F1 score, hallucination rate, or perplexity, depending on the task.
Acceptance thresholds must be documented. For example, what level of hallucination is tolerable in a customer support bot? What accuracy rate is required for compliance documentation generation? Defining these thresholds ensures accountability and prevents endless pilot cycles.

Deployment and Operational Resilience

Enterprises cannot treat GenAI as an experimental tool once it enters production. It must meet the same standards of operational excellence as any other enterprise system.
This means designing deployment patterns such as blue/green releases or canary rollouts. It requires telemetry for monitoring performance, drift detection to identify when models deviate from expected behavior, and versioning to manage incremental improvements.
Critical safeguards include rollback procedures and kill-switch mechanisms. Executives should insist on these from day one, ensuring that any malfunction can be contained without disrupting core operations.

Human-in-the-Loop Operating Model

Despite advances, GenAI remains probabilistic and therefore prone to error. Enterprises should establish a human-in-the-loop policy that defines where oversight is mandatory.
The rule of thumb: any workflow that alters data, moves money, or changes customer state must require human approval. In such workflows, GenAI should accelerate human productivity by generating drafts, recommendations, or insights, while final authority remains with professionals.
This model provides both accountability and speed. It prevents uncontrolled automation while still delivering efficiency gains.

Conclusion – Benefit vs. Risk

Ultimately, every GenAI initiative comes down to benefit versus risk. Enterprises must quantify both.
On the benefit side, estimate potential productivity improvements, cost reductions, or revenue uplift. On the risk side, quantify error costs, regulatory exposure, and reputational damage. The ratio between expected upside and downside is the best decision filter.
Projects with significant upside relative to downside should move forward. Projects with marginal benefit but existential risk should be deprioritized. This analytical rigor keeps enthusiasm grounded in financial discipline.
GenAI has the potential to transform enterprises. It can accelerate workflows, create new business capabilities, and reshape customer experiences. But adoption must be deliberate, structured, and disciplined.
Executives should evaluate each potential use case across multiple dimensions: business alignment, organizational readiness, architecture, data strategy, compliance, integration, testing, deployment, human oversight, and benefit-risk balance. These filters might look like barriers, but in fact they are enablers. They give enterprises the confidence to deploy GenAI where it delivers real value, while protecting against misapplication.
The enterprises that succeed will not be those that experiment randomly, but those that approach GenAI adoption as a governed enterprise initiative embedded into their SDLC, operating models, and strategic plans. For them, GenAI will not be hype. It will be a sustained source of competitive differentiation.